日本語 
Kura Oncology, Inc., and Kyowa Kirin Co., Ltd. announced Kura submitted a New Drug Application (NDA) for ziftomenib, a highly selective, once-daily, oral, investigational menin inhibitor, for the treatment of…
Latest News
Panasonic Corporation Launches RizMo Femtech Service
Panasonic has launched RizMo. This new health navigation service enters the inner…
ConcertAI Adds ASCO® Automation to AI Cancer Tools
ConcertAI, a leader in oncology generative and agentic AI SaaS and multi-modal…
AI Medical Services appoints Yasuji Takikawa as New CEO
AI Medical Services Inc., a developer of endoscopic image diagnosis support AI,…
Cellares with Mitsui to Launch Japan’s First IDMO Factory
Cellares, a pioneer in automated cell therapy manufacturing, in collaboration with Mitsui…
Quadritics Inc Raises ¥600M for Epilepsy Alert Device
Quadritics Inc., a developer of innovative medical devices in the digital health…
SCSK Corp launches “Uwell” health management service
SCSK Corporation is the only company in Japan to have been selected…
Hitori IT Partners with Gunma for Mental Health Hotline
The One-Man IT Administrator Association, a general incorporated association, has partnered with…
JCB With Noage Expand Medical Tourism for Indonesians
JCB International Co., Ltd., Japan’s only international payment brand, has signed a…
Latest Article
English